The estimated Net Worth of Joseph Gerard Flanagan is at least $58 Milion dollars as of 16 August 2022. Mr. Flanagan owns over 600,000 units of R1 RCM stock worth over $42,250,161 and over the last 15 years he sold RCM stock worth over $10,915,000. In addition, he makes $4,859,860 as President, Chief Executive Officer oraz Director at R1 RCM.
Joseph has made over 7 trades of the R1 RCM stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 600,000 units of RCM stock worth $1,452,000 on 16 August 2022.
The largest trade he's ever made was exercising 3,442,152 units of R1 RCM stock on 22 December 2020 worth over $48,603,186. On average, Joseph trades about 150,555 units every 27 days since 2010. As of 16 August 2022 he still owns at least 2,992,221 units of R1 RCM stock.
You can see the complete history of Mr. Flanagan stock trades at the bottom of the page.
Joseph Gerard Flanagan serves as President, Chief Executive Officer, Director of the Company. Mr. Flanagan has served as our President and Chief Executive Officer and as a member of our board of directors since May 2016, after having served as our President and Chief Operating Officer since April 2016. Mr. Flanagan joined R1 as Chief Operating Officer in April 2013 after serving as Senior Vice President of worldwide operations and supply chain at Applied Materials, Inc. from February 2010 to April 2013, and previously as President of Nortel Business Services for Nortel Networks. Previously, Mr. Flanagan served most of his career working for General Electric (GE), holding leadership positions in many divisions. Mr. Flanagan also currently serves as a director of GoHealth.
As the President, Chief Executive Officer oraz Director of R1 RCM, the total compensation of Joseph Flanagan at R1 RCM is $4,859,860. There are no executives at R1 RCM getting paid more.
Joseph's mailing address filed with the SEC is C/O R1 RCM INC., 433 W. ASCENSION WAY, SUITE 200, MURRAY, UT, 84123.
Over the last 8 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan oraz John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.
R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
R1 RCM executives and other stock owners filed with the SEC include: